507 related articles for article (PubMed ID: 19403562)
1. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.
Valkenburg O; Uitterlinden AG; Piersma D; Hofman A; Themmen AP; de Jong FH; Fauser BC; Laven JS
Hum Reprod; 2009 Aug; 24(8):2014-22. PubMed ID: 19403562
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.
Valkenburg O; Uitterlinden AG; Themmen AP; de Jong FH; Hofman A; Fauser BC; Laven JS
Hum Reprod; 2011 Oct; 26(10):2902-11. PubMed ID: 21803757
[TBL] [Abstract][Full Text] [Related]
3. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
4. PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms.
Mohiyiddeen L; Salim S; Mulugeta B; McBurney H; Newman WG; Pemberton P; Nardo LG
Gynecol Endocrinol; 2012 May; 28(5):375-7. PubMed ID: 22429116
[TBL] [Abstract][Full Text] [Related]
5. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.
Almawi WY; Hubail B; Arekat DZ; Al-Farsi SM; Al-Kindi SK; Arekat MR; Mahmood N; Madan S
J Assist Reprod Genet; 2015 Apr; 32(4):607-14. PubMed ID: 25649397
[TBL] [Abstract][Full Text] [Related]
6. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.
Overbeek A; Kuijper EA; Hendriks ML; Blankenstein MA; Ketel IJ; Twisk JW; Hompes PG; Homburg R; Lambalk CB
Hum Reprod; 2009 Aug; 24(8):2007-13. PubMed ID: 19401323
[TBL] [Abstract][Full Text] [Related]
7. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.
Cui L; Zhao H; Zhang B; Qu Z; Liu J; Liang X; Zhao X; Zhao J; Sun Y; Wang P; Li T; Shi Y; Chen ZJ
Hum Reprod; 2013 Feb; 28(2):538-44. PubMed ID: 23208300
[TBL] [Abstract][Full Text] [Related]
9. FSH receptor gene p. Thr307Ala and p. Asn680Ser polymorphisms are associated with the risk of polycystic ovary syndrome.
Kim JJ; Choi YM; Hong MA; Chae SJ; Hwang K; Yoon SH; Ku SY; Suh CS; Kim SH
J Assist Reprod Genet; 2017 Aug; 34(8):1087-1093. PubMed ID: 28547204
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
13. The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population.
Capalbo A; Sagnella F; Apa R; Fulghesu AM; Lanzone A; Morciano A; Farcomeni A; Gangale MF; Moro F; Martinez D; Ciardulli A; Palla C; Uras ML; Spettu F; Cappai A; Carcassi C; Neri G; Tiziano FD
Clin Endocrinol (Oxf); 2012 Jul; 77(1):113-9. PubMed ID: 22356187
[TBL] [Abstract][Full Text] [Related]
14. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
Van Nieuwerburgh F; Stoop D; Cabri P; Dhont M; Deforce D; De Sutter P
Gynecol Endocrinol; 2008 Dec; 24(12):669-73. PubMed ID: 19172534
[TBL] [Abstract][Full Text] [Related]
15. Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China.
Wu XQ; Xu SM; Liu JF; Bi XY; Wu YX; Liu J
J Assist Reprod Genet; 2014 Mar; 31(3):371-7. PubMed ID: 24390680
[TBL] [Abstract][Full Text] [Related]
16. Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women.
Peng CY; Long XY; Lu GX
Reprod Fertil Dev; 2010; 22(5):881-5. PubMed ID: 20450840
[TBL] [Abstract][Full Text] [Related]
17. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Blank SK; McCartney CR; Marshall JC
Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
[TBL] [Abstract][Full Text] [Related]
18. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
[TBL] [Abstract][Full Text] [Related]
19. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
